Advertisement

Supply Chain



The Food and Drug Administration is working to make naloxone more available, stated Karen Mahoney, MD, deputy director for the division of nonprescription drug products at the Center for Drug Evaluation and Research, in a post on the agency's website.

AstraZeneca invested an additional $140 million in Moderna Therapeutics, a Cambridge, Mass.-based biotech developing drug treatments using messenger RNA, reported Reuters.

Pressure to slash drug prices from both the Democratic and Republican presidential candidates, as well as leaders and consumer advocates around the globe, could spur changes to the drug pricing model, according to Fortune.

Many Olympic athletes take advantage of a loophole to the anti-doping rules that ban the use of performance enhancing drugs through a practice known as "legal doping," or taking legal prescription medications that may improve performance, according to NPR.

Advertisement

Most Read

Advertisement
Advertisement